AVGR Quarterly Earnings. Should You Buy?


AVGR Quarterly Earnings. Should You Buy?: Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today reported results for the fourth quarter ended December 31, 2020. Fourth Quarter and Recent Highlights Revenue increased 19% sequentially to $2.7 million, the highest level in […]

Comments

Popular posts from this blog

CWEB - Many household products contain antimicrobial chemicals banned from soaps by the FDA

Thousands of Amazon Employees Receive Layoff Mails, Jeff Bezos’ Surprise Visit at Meeting Sparks Fear Among Washington Post Staff